Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ · Healthcare
Xeris Biopharma Holdings, Inc. Price to Book Ratio 2018–2026
Price to book (P/B) ratio for Xeris Biopharma Holdings, Inc. (XERS): market cap divided by shareholder equity. As of March 31, 2026 it is 75.26.
From: 09/30/2021To: 03/31/2026
Stock Price
Book Value
Price to Book
Xeris Biopharma Holdings, Inc. Price to Book Ratio — FAQ
Xeris Biopharma Holdings, Inc. (XERS) price to book ratio over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see XERS's price to book ratio history?
The chart and table above show Xeris Biopharma Holdings, Inc.'s price to book ratio by year and by quarter, including the growth rate.